PMID: 8939702Oct 1, 1996Paper

A hybrid modular polyketide synthase obtained by domain swapping

Chemistry & Biology
M OliynykP F Leadlay

Abstract

Modular polyketide synthases govern the synthesis of a number of medically important antibiotics, and there is therefore great interest in understanding how genetic manipulation may be used to produce hybrid synthases that might synthesize novel polyketides. In particular, we aimed to show whether an individual domain can be replaced by a comparable domain from a different polyketide synthase to form a functional hybrid enzyme. To simplify the analysis, we have used our previously-developed model system DEBS1-TE, consisting of the first two chain-extension modules of the erythromycin-producing polyketide synthase of Saccharopolyspora erythraea. We show here that replacing the entire acyltransferase (AT) domain from module 1 of DEBS1-TE by the AT domain from module 2 of the rapamycin-producing polyketide synthase leads, as predicted, to the synthesis of two novel triketide lactones in good yield, in place of the two lactones produced by DEBS1-TE. Both of the novel products specifically lack a methyl group at C-4 of the lactone ring. Although the AT domain is a core structural domain of a modular polyketide synthase, it has been swapped to generate a truly hybrid multienzyme with a rationally altered specificity of chain extensio...Continue Reading

References

Jan 1, 1990·Annual Review of Genetics·D A Hopwood, D H Sherman
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·T SchweckeJ B Lester
Dec 3, 1993·Science·R McDanielC Khosla
Feb 1, 1996·Nature Structural Biology·J StauntonP F Leadlay
Sep 1, 1995·Chemistry & Biology·K E WiesmannP F Leadlay

❮ Previous
Next ❯

Citations

May 10, 2000·Trends in Biotechnology·R LalD Tuteja
Jul 4, 1998·Trends in Biotechnology·A E NixonS J Benkovic
Sep 30, 1998·Current Opinion in Biotechnology·C W Carreras, D V Santi
Mar 21, 1998·Trends in Microbiology·R H Baltz
Oct 24, 1998·Bioorganic & Medicinal Chemistry·J R JacobsenC Khosla
Apr 26, 2003·Current Opinion in Chemical Biology·Grace F Liou, Chaitan Khosla
Aug 1, 1997·Current Opinion in Chemical Biology·P F Leadlay
Aug 6, 1998·Current Opinion in Chemical Biology·J Staunton
Jul 17, 1998·Current Opinion in Chemical Biology·J R Jacobsen, C Khosla
Mar 6, 1999·Current Opinion in Microbiology·C R Hutchinson
Mar 6, 1999·Current Opinion in Microbiology·J Nielsen
Apr 1, 1997·Nature Biotechnology·D Hopwood
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·D L StassiL Katz
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·K A Reynolds
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·R McDanielG Ashley
May 31, 2013·Journal of the Royal Society, Interface·Briana J Dunn, Chaitan Khosla
Mar 10, 2001·Microbiology and Molecular Biology Reviews : MMBR·B A Pfeifer, C Khosla
Jun 29, 2000·Annual Review of Biochemistry·C KhoslaD E Cane
Mar 3, 2007·Annual Review of Biochemistry·Chaitan KhoslaDavid E Cane
Nov 10, 2001·Annual Review of Phytopathology·CL BenderJ Loper
Jun 1, 2005·Journal of Molecular Microbiology and Biotechnology·Steven BoakesPeter F Leadlay
Oct 13, 2006·PLoS Computational Biology·Holger Jenke-KodamaElke Dittmann
Jan 8, 2016·Journal of Industrial Microbiology & Biotechnology·Leonard Katz, Richard H Baltz
Jul 5, 2005·Expert Opinion on Investigational Drugs·J Staunton, B Wilkinson
Jan 17, 2012·Current Opinion in Biotechnology·Satoshi YuzawaJay D Keasling
Feb 17, 2009·Current Opinion in Chemical Biology·Chaitan KhoslaDavid E Cane
Nov 4, 2015·Chemistry & Biology·Kenny Bravo-RodriguezElsa Sanchez-Garcia
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·B Weisblum
Aug 1, 2015·Journal of the American Chemical Society·Joseph A ChemlerDavid H Sherman
Jul 28, 2007·Chemistry & Biology·Alice Y ChenChaitan Khosla
Apr 8, 2014·Journal of Molecular Biology·Andrea L EdwardsChaitan Khosla
Jul 30, 2002·Chemistry & Biology·Iain ThomasPeter F Leadlay
Dec 22, 2004·Chemistry & Biology·Kedar PatelRobert McDaniel
Oct 23, 1997·Chemistry & Biology·R McDanielC Khosla
Jan 1, 2014·FEMS Microbiology Letters·Matthew CummingsEriko Takano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.